Antiviral drugs in human therapy.
D000547:Amantadine / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D006566:Herpesviridae Infections / Q000517:prevention & control; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007251:Influenza, Human / Q000517:prevention & control; D007372:Interferons / Q000627:therapeutic use; D007546:Isoquinolines / Q000627:therapeutic use; D010093:Oxolinic Acid / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000517:prevention & control; D012293:Rifampin / Q000627:therapeutic use; D012899:Smallpox / Q000517:prevention & control; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014777:Virus Diseases / Q000517:prevention & control
D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D000998:Antiviral Agents; D007546:Isoquinolines; D013882:Thiosemicarbazones; D007372:Interferons; D000547:Amantadine; D010093:Oxolinic Acid; D007065:Idoxuridine; D012293:Rifampin